A public-private partnership between ARPA-H and VentureWell in support of the ARPANET-H nationwide health innovation network. Website is maintained by VentureWell staff.
The Investor Catalyst Hub is excited to feature a panel of representatives from investor and venture capital spoke organizations at our May member meeting. With a focus on health innovation and impact investing, we look forward to welcoming the following panelists for an engaging discussion: Erin Sietstra, Head of Investments, Hopelab; Erich Scheller, Director, TechAtlas […]
ARPA-H Program Manager Paul E. Sheehan, Ph.D., will join the Investor Catalyst Hub’s virtual monthly meeting to discuss the various programs in his portfolio.
Spokes are invited to join an exclusive virtual networking session that will feature three breakout rooms.
Learn about the ARPA-H Small Business Program, including how to submit an application, eligibility considerations, and details of current open topics.
Join the Investor Catalyst Hub to hear from a panel of spoke organizations working within digital health.
Learn more about what investors and venture capital firms look for when considering new investment opportunities in health care.
Tune in to a fireside chat with spoke members on the impact of artificial intelligence on health innovation.
To kick off the Investor Catalyst (IC) Hub’s second year, we’re excited to open our October monthly meeting to the public for a celebratory network showcase and year in review!
Attend the ARPA-H CATALYST Information Session to hear from Program Manager Andy Kilianski, Ph.D., about the program’s goals, technical areas of focus, and upcoming deadlines.
Tune in to a fireside chat with ARPA-H Program Manager Dr. Calvin Roberts to learn more about ARPA-H’s new OCULAB program.
Register to attend the virtual information session for ImagiNg Data EXchange (INDEX)–a brand new ARPA-H program that aims to revolutionize medical AI tool development.
Learn more about a new network survey that aims to gather insights from medical technology developers and manufacturers, healthcare providers, payors, and other key stakeholders about the typical pathways, exemplars, and specific challenges facing medical devices seeking reimbursement.